German-Italian Chamber of Commerce – The Business Platform for Italy
The German-Italian Chamber of Commerce (AHK Italien) belongs to the network of 130 German Chambers of Commerce in 90 countries around the world. Its function is to support the economic activities between Germany and Italy.
With around 600 members in Germany and Italy, the German-Italian Chamber of Commerce is a bilateral business association and a platform for networking, enjoying high consideration in the political and economic environment in both countries.
Through its service company, DEinternational Italia Srl, the Chamber offers high quality services to companies of both countries. Each year about 5,000 requests are processed, about 1,000 regular customers are assisted and about 100 Italian and German companies are introduced into the respective foreign market. The services are based on decades of experience in consulting and supporting companies in their internationalization process. High-level professional services meet high standards of content and quality and are systematically updated and developed further.
The cooperation with the worldwide network of German Chambers of Commerce allows the realization of international projects in various markets at the same time.
Contact Details
German-Italian Chamber of Commerce
Via Gustavo Fara,
26 20124
Milano
Tel.:+39 02 679131
Fax:+39 02 66980964
info@ahk-italien.it
www.ahk-italien.it
A roundup of some of the biggest stories from Italian pharma and healthcare, including Italfarmaco’s FDA approval for its DMD treatment; Alfasigma’s acquisition of Galapagos’s Jyseleca, the antibiotics deal between…
The grants and loans allocated by the European Union’s Recovery and Resilience Facility (RRF), a large part of which have been assigned to healthcare, set out to mitigate the economic…
After former CEO Pierluigi Antonelli abruptly announced his departure last month, the Italian mid-cap has signed on former Gilead leader, Jacopo Andreose, as its new chief executive. [I am]…
Angelini Pharma CEO Pierluigi Antonelli has announced that he is leaving his position with immediate effect, posing the question of what comes next for the leading Italian mid-cap. Antonelli,…
The electoral victory of the centre-right coalition in Italy should see far-right firebrand Giorgia Meloni replace former European Central Bank President Mario Draghi as Prime Minister at the end of…
Digitalisation has become a buzz word in in the global life sciences sector. In Italy, digital transformation has taken on special significance as one of the principal goals encompassed in…
The Italian system requires drug companies to go through approvals at a national level with the Italian Medicines Agency (AIFA), only to then confront the country’s 21 regional authorities who…
Historically, SIFI has been a modest local player focused on ophthalmic products, but in recent years the company has set some ambitious goals for itself—becoming a leading force in European…
Seasoned executive Pierluigi Antonelli went from a career in big pharma to Angelini Pharma, a midsized Italian company that has been undergoing major transformation. He shares the motivation behind the…
Collectively representing almost 400 companies operating in Italy, Farmindustria, Egualia (formerly Assogenerici) and Assobiotec respectively promote the interests of innovative pharmaceutical companies—both foreign and Italian-owned— the generics, biosimilars and value-added…
As the European Union’s largest beneficiary of the Next Generation EU (NGEU) package, aimed at boosting the EU’s economy following the COVID-19 pandemic, Italy will receive some EUR 235 billion…
While Italy’s biotech landscape is generally held to be somewhat immature in comparison to more established markets such as Germany, France or the UK, that does not imply a deficit…
See our Cookie Privacy Policy Here
